Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating cancer with a combination of a PD-1 antagonist and dinaciclib

Treating cancer with a combination of a PD-1 antagonist and dinaciclib

US Patent 9827309 · Granted Nov 28, 2017

Estimated economic value: $70,949,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TREM2 antibodies and related methods2025
Anti-MARCO antibodies and uses thereof2025
Anti-TREM1 antibodies and related methods2024
Anti-MARCO antibodies and uses thereof2023
Anti-TREM2 antibodies and related methods2022
Anti-TREM1 antibodies and related methods2020
Compounds and compositions for treating hematological disorders2020
Anti-TREM2 antibodies and related methods2019
Combination therapies for cancer2018
Method for treating cancer2018
Method for treating cancer2018
MDL-1 ligand2016